Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Aug 2, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-08-01$55.99/sh−2,500$139,975→ 107,384 total
Footnotes (2)
- [F1]This is a scheduled sale from 10b5-1 trading plan.
- [F2]Includes 323 shares from 4/30/2022 ESPP purchase.